Capital Markets: Equity (International Firms)
China
8 years ranked
Provided by Kirkland & Ellis
Dr. Mengyu Lu heads the Firm’s Asia capital markets practice. Dr. Lu has extensive experience in initial public offerings, SPACs, pre-IPO financings, mergers and acquisitions, and various follow-on offerings or compliance matters by listed companies. She is particularly well recognized in advising issuers in the “new economy” sectors, including healthcare, semiconductor, artificial intelligence, TMT and consumer sectors. In addition to corporate issuers, she also advises major investment banks, private equity and venture capital firms on capital markets and M&A matters.
Provided by Chambers
Lu Mengyu has notable experience acting for life sciences and biotech clients, with a strong track record of advising on 18A IPOs.
Provided by Chambers
Dr. Lu attaches equal importance to strategic thinking and practical implementation, ensuring the project is progressing steadily and delivered on schedule with synergy between all parties.
With her leadership and ability to integrate resources and coordinate projects she efficiently mobilises teams and cross-regional resources at all critical stages to ensure they can be delivered.
Mengyu successfully solved a problem that was originally considered unsolvable and proposed a creative and feasible solution.
Chambers is the leading data and intelligence partner for the legal sector.